Utilisation of predictive, prenatal and diagnostic testing for huntington 's disease in johannesburg

South African Medical Journal

Volumn 89, Issue 7, 1999, Pages 774-778

  Kromberg, J G R ^a   Krause, A ^a   Spurdle, A B ^a   Temlett, J A ^a   Lucas, M ^a   Rodseth, D ^a   Stevens, G ^a   Jenkins, T ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC TEST; DNA DETERMINATION; FAMILY HISTORY; FEMALE; GENETIC COUNSELING; HEALTH CARE UTILIZATION; HUMAN; HUNTINGTON CHOREA; MALE; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDY;

FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HUNTINGTON DISEASE; LINKAGE (GENETICS); MALE; PEDIGREE; PREGNANCY; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA;

EID: 0032884248     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Harper PS. llmitin-4o,:'-4 LVf.iSi-. 2nd ed. London: Saunders, 1996.
2. Conneally PM. Huntington's disease: genetics and epidemiology. Am J Hum Genet 1984, 36: 506-526.
3. Gusella JF, Wexler NS, Lonneally PM, et al A polymorphic DMA marker genetically linked to Huntington's disease. Nature 1983, 306: 234-238.
4. the Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993,72:971-983.
5. Kremei B, Goldberg P, Andrew SE. et al A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. \' En%l ! Mcd 1994; 330: 1401-1406
6. McMeil 5M, Novelletto A, Srinidhi J, et al. Reduced penetrance of the Iiunfington's disease mutation. Hunt Mo! Genet 1997; 6: 775-779
7. Rubinsztein DC, Leggo J, Coles R, et a!. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Gene! 1996; 59: 16-22.
8. Brinkman RK, Mezei MM, Theilmann J, Almqvist E, Hayden MR. The likelihood ot being affected with Huntington disease by a particular age, for a specific CAG size Am J Hum Geih't 1997; 60: 1202-1210 9.
9. Craufurd D, Dodge A. Mutation size and age at onset in 1 luntington's disease. J Mud Genet 199-4; 30: 1008-1011
10. Andrew SE, Goldberg VP, Kremer B, et al. 'Ihe relationship between trinucloetide (LAG) repeal length and clinical features of Huntington's disease. Nat Genet 1993; 4: 398-403.
11. Kremer B, Almqvist E, Theilmann ),.'( al. Sex-dependent mechanisms tor expansion and contractions of the CAG repeat on affected Huntington disease chromosomes. Am J Hum Genet 1995, 57:343-350.
12. Ball D, Harper PS, Tyler A, ei ai Ethical and social issues in pa-symptomatic testing for Huntington's disease, a European collaborative study. J Med Genet 1993; 30: 1028-1035.
13. Harper PS. Fix-symptomatic testing for Huntington's disease: a world wide survey. J Med Gent'1 1993; 30: 1020-1022.
14. Kessler S. Predictive testing for Huntington's disease: a psychologist's view. Am ! Meti Genet 1994; 54: 161-166.
15. Quaid KA Pa-symptomatic testing tor Huntington's disease in the United States. Am J Hum Genet 1993:53:785-787.
16. Simpson S, Harding AE. Predictive testing tor Huntington's disease: atfer the gene. J Med Genet 1993; 30: 1036-1038.
17. Harper PS. A specific mutation tor Huntington's disease. J Meti Genet 1993; 30: 975-977.
18. Craufurd D, Tyler A. Predictive testing for Huntington's disease: protocol ot the UK Huntington's Prediction Consortium. J Med Genet 1992; 29: 915-918.
19. Lipe H, Schultz A, Bird TD. Risk factors for suicide in Huntington's disease. A retrospective case controlled study. Am I Med Genet 1993; 48: 231-233.
20. Van der Steenstraten IM, Tibben A, Roos RAG, Van de Kamp J(P, Niermeijer MF. Predictive testing for Huntington disease: Nonparticipants compared with participants in the Dutch program Am J Hum Gencl 1994; 55: 618-625.
21. Burgess M, Adam S, Bloch M, Hayden M. Dilemmas of anonymous predictive testing for Huntington disease- privacy vs optima! care. Am }Med Genet 1997, 71: 197-201.
22. Lawson K, Wiggins S, Green T, et a!. Adverse psychological events occurring in the Iirst year after predictive testing for Huntington's disease. J Med Gemi 1996; 33: 856-862.
23. Decruyenaere M, hvers-Kiebooms G, Boogaerfs A, et ni Prediction of psychological functioning one year after the predictive test for Huntinglon's disease and impact ot the test result on reproductive decision making. J Med Genet 1996; 33: 737-743.
24. Spurdle A, Kromberg J, Rosendorff J, Jenkins H Prenatal diagnosis for Huntington's disease: a molecular and psychological study. Prt'tiat Diagn 1991; 11: 177-185.
25. Silber K, Kromberg J. Temlett J, et al Huntington's disease confirmed by genetic testing in five African families. .-Vie:- Dcvrd 1998; 13: 726-730.